142 related articles for article (PubMed ID: 10225717)
1. Ig-Therasorb immunoadsorption for selective removal of human immunoglobulins in diseases associated with pathogenic antibodies of all classes and IgG subclasses, immune complexes, and fragments of immunoglobulins.
Koll RA
Ther Apher; 1998 May; 2(2):147-52. PubMed ID: 10225717
[TBL] [Abstract][Full Text] [Related]
2. IG-therasorb immunoapheresis in orthotopic xenotransplantation of baboons with landrace pig hearts.
Brenner P; Reichenspurner H; Schmoeckel M; Wimmer C; Rucker A; Eder V; Meiser B; Hinz M; Felbinger T; Müller-Höcker J; Hammer C; Reichart B
Transplantation; 2000 Jan; 69(2):208-14. PubMed ID: 10670628
[TBL] [Abstract][Full Text] [Related]
3. The influence of antibody and complement removal with a Ig-Therasorb column in a xenogeneic working heart model.
Brenner P; Hinz M; Huber H; Schmoeckel M; Reichenspurner H; Meiser B; Hammer C; Reichart B
Eur J Cardiothorac Surg; 1999 May; 15(5):672-9. PubMed ID: 10386416
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of different immunoadsorption columns for anti-A/B antibody depletion.
Speer C; Kälble F; Pego da Silva L; Nusshag C; Schaier M; Becker LE; Klein K; Beimler J; Sommerer C; Leo A; Süsal C; Mehrabi A; Zeier M; Morath C
Atheroscler Suppl; 2019 Dec; 40():68-72. PubMed ID: 31447215
[TBL] [Abstract][Full Text] [Related]
5. Removal of baboon and human antiporcine IgG and IgM natural antibodies by immunoadsorption. Results of in vitro and in vivo studies.
Leventhal JR; John R; Fryer JP; Witson JC; Derlich JM; Remiszewski J; Dalmasso AP; Matas AJ; Bolman RM
Transplantation; 1995 Jan; 59(2):294-300. PubMed ID: 7839454
[TBL] [Abstract][Full Text] [Related]
6. LDL-Therasorb immunoadsorption for the treatment of severe hypercholesterolemia refractory to conventional therapy.
Koll RA
Ther Apher; 1998 May; 2(2):142-6. PubMed ID: 10225716
[TBL] [Abstract][Full Text] [Related]
7. Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb).
Jansen M; Schmaldienst S; Banyai S; Quehenberger P; Pabinger I; Derfler K; Hörl WH; Knöbl P
Br J Haematol; 2001 Jan; 112(1):91-7. PubMed ID: 11167789
[TBL] [Abstract][Full Text] [Related]
8. New trends in specific immunoadsorption.
Ullrich H; Kuehnl P
Transfus Apher Sci; 2004 Jun; 30(3):223-31. PubMed ID: 15172628
[TBL] [Abstract][Full Text] [Related]
9. Prevention of hyperacute xenograft rejection in orthotopic xenotransplantation of pig hearts into baboons using immunoadsorption of antibodies and complement factors.
Brenner P; Reichenspurner H; Schmoeckel M; Wimmer C; Rucker A; Eder V; Meiser B; Hinz M; Felbinger T; Hammer C; Reichart B
Transpl Int; 2000; 13 Suppl 1():S508-17. PubMed ID: 11112063
[TBL] [Abstract][Full Text] [Related]
10. Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption.
Wallukat G; Reinke P; Dörffel WV; Luther HP; Bestvater K; Felix SB; Baumann G
Int J Cardiol; 1996 May; 54(2):191-5. PubMed ID: 8803685
[TBL] [Abstract][Full Text] [Related]
11. Elimination of acquired factor VIII antibodies by extracorporal antibody-based immunoadsorption (Ig-Therasorb).
Knöbl P; Derfler K; Korninger L; Kapiotis S; Jäger U; Maier-Dobersberger T; Hörl W; Lechner K; Pabinger I
Thromb Haemost; 1995 Oct; 74(4):1035-8. PubMed ID: 8560408
[TBL] [Abstract][Full Text] [Related]
12. Current topics on immunoadsorption therapy.
Nakaji S
Ther Apher; 2001 Aug; 5(4):301-5. PubMed ID: 11724516
[TBL] [Abstract][Full Text] [Related]
13. Five years' experience at one centre with protein A immunoadsorption in patients with deleterious allo/autoantibodies (anti-HLA antibodies, autoimmune bleeding disorders) and post-transplant patients relapsing with focal glomerular sclerosis.
Kriaa F; Laurian Y; Hiesse C; Tchernia G; Charpentier B
Nephrol Dial Transplant; 1995; 10 Suppl 6():108-10. PubMed ID: 8524477
[TBL] [Abstract][Full Text] [Related]
14. Immunoadsorption therapy (therasorb) in patients with severe lupus erythematosus.
Graninger M; Schmaldienst S; Derfler K; Graninger WB
Acta Med Austriaca; 2002; 29(1):26-9. PubMed ID: 11899750
[TBL] [Abstract][Full Text] [Related]
15. Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity.
Biesenbach P; Schmaldienst S; Smolen JS; Hörl WH; Derfler K; Stummvoll GH
Atheroscler Suppl; 2009 Dec; 10(5):114-21. PubMed ID: 20129388
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal immunoadsorption for the treatment of haemophilic patients with inhibitors to factor VIII or IX.
Knöbl P; Derfler K
Vox Sang; 1999; 77 Suppl 1():57-64. PubMed ID: 10529691
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic immunoadsorption increases the level of circulating soluble HLA molecules.
Poehlau D; Kiltz U; Rieks M; Hoffmann V; Rebmann V; Schimrigk S; Grosse-Wilde H; Przuntek H
Vox Sang; 2000; 78(2):119-21. PubMed ID: 10765148
[TBL] [Abstract][Full Text] [Related]
18. [Immune thrombocytopenia, anemia and leukopenia during pregnancy. Successful therapy with extracorporeal immunoadsorption].
Julius U; Patzak A; Schaich M; Ehninger G; Kamin G
Dtsch Med Wochenschr; 1997 Feb; 122(8):220-4. PubMed ID: 9081810
[TBL] [Abstract][Full Text] [Related]
19. Removal of immunoglobulins by a protein A versus an antihuman immunoglobulin G-based system: evaluation of 602 sessions of extracorporeal immunoadsorption.
Matic G; Hofmann D; Winkler R; Tiess M; Michelsen A; Schneidewind JM; Hebestreit G; Keysser M; Müller W; Kinze EM; Ramlow W
Artif Organs; 2000 Feb; 24(2):103-7. PubMed ID: 10718762
[TBL] [Abstract][Full Text] [Related]
20. Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti-glycoprotein IIb-IIIa antibodies.
Martin I; Kriaa F; Proulle V; Guillet B; Kaplan C; D'Oiron R; Debré M; Fressinaud E; Laurian Y; Tchernia G; Charpentier B; Lambert T; Dreyfus M
Br J Haematol; 2002 Dec; 119(4):991-7. PubMed ID: 12472579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
